<DOC>
	<DOCNO>NCT00530140</DOCNO>
	<brief_summary>Poor prognosis follicular lymphoma patient estimate median overall survival 5-6 year . The propose trial offer life-time idiotypic vaccination patient first relapse/progression achieve second ( first , case patient never achieve complete response follow standard first-line treatment ) complete response autologous stem cell transplant prior vaccination start . The ultimate goal cure , define vaccine-maintained complete response last least 10 year least twice long patient 's first complete response .</brief_summary>
	<brief_title>Idiotypic Vaccination Follicular Lymphoma Patients</brief_title>
	<detailed_description>Idiotypic vaccination already prove capable ( respond patient ) : biological efficacy , capacity induce idiotype- tumor-specific immune response ( Kwak LW et al . NEJM 1992 ) ; clinical efficacy , capacity induce specific immune response able kill vivo follicular lymphoma cell survive pre-vaccine chemotherapy ( Bendandi M et al . Nature Med 1999 ) : clinical benefit , capacity prolong survival respond patient ( Inoges et al . JNCI 2006 ) . Now , want test whether also capable contribute ultimate goal prevent relapse indefinitely respond patient .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulin Idiotypes</mesh_term>
	<criteria>least one following : FLIPI score 3 thru 5 diagnosis and/or relapse First complete response shorter 3 year , maintenance ( Interferon , Rituximab , etc ) treatment administer , 5 year maintenance treatment administer No treatment able induce complete response autologous stem cell transplant Poorprognosis genomic profiling following : Unavailability harvestable lymph node least cm 2x2x2 Life expectancy &lt; 1 year Abnormal heart liver kidney function ECOG Performance Status &gt; 2 Failure sign inform consent enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Follicular Lymphoma</keyword>
	<keyword>Idiotype vaccine</keyword>
</DOC>